
pmid: 23025999
Dipeptidyl peptidase IV (DPP-4) inhibitors have been shown to enhance GLP-1 levels and thereby improve hyperglycemia in type II diabetes. From a small fragment hit, using structure-based design, we have discovered a new class of non-covalent, potent and selective DPP-4 inhibitors.
Enzyme Activation, Models, Molecular, Dipeptidyl-Peptidase IV Inhibitors, Inhibitory Concentration 50, Dose-Response Relationship, Drug, Catalytic Domain, Drug Design, Humans, Pyrimidinones, Crystallography, X-Ray
Enzyme Activation, Models, Molecular, Dipeptidyl-Peptidase IV Inhibitors, Inhibitory Concentration 50, Dose-Response Relationship, Drug, Catalytic Domain, Drug Design, Humans, Pyrimidinones, Crystallography, X-Ray
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 23 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
